Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 29085 | 158 | 28.5 | 59% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2444 | 3620 | CARNITINE//L CARNITINE//PROPIONYL L CARNITINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | MILDRONATE | Author keyword | 49 | 64% | 30% | 48 |
| 2 | MET 88 | Author keyword | 11 | 100% | 4% | 6 |
| 3 | GAMMA BUTYROBETAINE HYDROXYLASE INHIBITOR | Author keyword | 6 | 100% | 3% | 4 |
| 4 | MELDONIUM | Author keyword | 3 | 42% | 3% | 5 |
| 5 | GAMMA BUTYROBETAINE | Author keyword | 2 | 26% | 4% | 6 |
| 6 | MEXICOR | Author keyword | 2 | 36% | 3% | 4 |
| 7 | LONG CHAIN ACYLCARNITINE | Author keyword | 1 | 25% | 2% | 3 |
| 8 | BBOX | Author keyword | 1 | 50% | 1% | 1 |
| 9 | CYTOSOLIC COMPARTMENT | Author keyword | 1 | 50% | 1% | 1 |
| 10 | GLUT1 EXPRESSION | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MILDRONATE | 49 | 64% | 30% | 48 | Search MILDRONATE | Search MILDRONATE |
| 2 | MET 88 | 11 | 100% | 4% | 6 | Search MET+88 | Search MET+88 |
| 3 | GAMMA BUTYROBETAINE HYDROXYLASE INHIBITOR | 6 | 100% | 3% | 4 | Search GAMMA+BUTYROBETAINE+HYDROXYLASE+INHIBITOR | Search GAMMA+BUTYROBETAINE+HYDROXYLASE+INHIBITOR |
| 4 | MELDONIUM | 3 | 42% | 3% | 5 | Search MELDONIUM | Search MELDONIUM |
| 5 | GAMMA BUTYROBETAINE | 2 | 26% | 4% | 6 | Search GAMMA+BUTYROBETAINE | Search GAMMA+BUTYROBETAINE |
| 6 | MEXICOR | 2 | 36% | 3% | 4 | Search MEXICOR | Search MEXICOR |
| 7 | LONG CHAIN ACYLCARNITINE | 1 | 25% | 2% | 3 | Search LONG+CHAIN+ACYLCARNITINE | Search LONG+CHAIN+ACYLCARNITINE |
| 8 | BBOX | 1 | 50% | 1% | 1 | Search BBOX | Search BBOX |
| 9 | CYTOSOLIC COMPARTMENT | 1 | 50% | 1% | 1 | Search CYTOSOLIC+COMPARTMENT | Search CYTOSOLIC+COMPARTMENT |
| 10 | GLUT1 EXPRESSION | 1 | 50% | 1% | 1 | Search GLUT1+EXPRESSION | Search GLUT1+EXPRESSION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BUTYROBETAINE HYDROXYLASE INHIBITOR | 37 | 81% | 14% | 22 |
| 2 | MET 88 | 37 | 100% | 9% | 14 |
| 3 | MILDRONATE | 21 | 69% | 11% | 18 |
| 4 | CARNITINE SYNTHESIS | 8 | 100% | 3% | 5 |
| 5 | CARNITINE BIOSYNTHESIS | 3 | 24% | 8% | 12 |
| 6 | HYDROXYLASE INHIBITOR | 3 | 50% | 3% | 4 |
| 7 | GAMMA BUTYROBETAINE | 1 | 18% | 4% | 7 |
| 8 | ACID OXIDATION INHIBITOR | 1 | 50% | 1% | 1 |
| 9 | ANTHOPLEURINE | 1 | 50% | 1% | 1 |
| 10 | HEPATIC CARNITINE | 1 | 50% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Mildronate: An antiischernic drug for neurological indications | 2005 | 18 | 27 | 70% |
| Mildronate: Cardioprotective action through carnitine-lowering effect | 2002 | 60 | 26 | 42% |
| Mildronate and its Neuroregulatory Mechanisms: Targeting the Mitochondria, Neuroinflammation, and Protein Expression | 2013 | 1 | 74 | 23% |
| New methods of anti-ischemic therapy optimisation | 2010 | 0 | 3 | 33% |
| Mildronate in cardiology practice - current evidence, ongoing research, and future perspectives | 2012 | 1 | 21 | 14% |
| MET-88: SR Ca2+-uptake stimulator for treating chronic heart failure | 1999 | 2 | 13 | 23% |
| Applied chemistry of 1,1-dimethylhydrazine and its derivatives | 1998 | 3 | 33 | 24% |
| Mildronate potential in patients with cardiovascular disease | 2010 | 1 | 26 | 12% |
| The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure | 2002 | 43 | 140 | 10% |
| Main therapeutic principles in premenopausal women | 2011 | 0 | 10 | 10% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CHAIR MED THER Y | 0 | 33% | 0.6% | 1 |
| 2 | CLIN INTERNAL DIS PROPEDEUT | 0 | 33% | 0.6% | 1 |
| 3 | CHAIR INTERNAL DIS 2 | 0 | 17% | 1.3% | 2 |
| 4 | DISPENSARY | 0 | 25% | 0.6% | 1 |
| 5 | MOSCOW REG CARDIOL | 0 | 25% | 0.6% | 1 |
| 6 | BIOCHEM FREE RAD | 0 | 100% | 0.6% | 1 |
| 7 | CHAIR INTERNAL DIS PEDIAT | 0 | 100% | 0.6% | 1 |
| 8 | CHAIR THEORET CLIN BIOCHEM | 0 | 100% | 0.6% | 1 |
| 9 | CHAIR THER YSTOMATOL | 0 | 100% | 0.6% | 1 |
| 10 | METABOL CARDIOVASC DRUG DISCOVERY | 0 | 100% | 0.6% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000180502 | CARNITINE//L CARNITINE//PROPIONYL L CARNITINE |
| 2 | 0.0000148141 | GLYCEROL OUTPUT//OXFENICINE//METHYLPALMOXIRATE |
| 3 | 0.0000147235 | TRIMETAZIDINE//TRIMETAZIDINE MB//TRIMETASIDINE |
| 4 | 0.0000098493 | CARNITINE PALMITOYLTRANSFERASE//CARNITINE PALMITOYLTRANSFERASE DEFICIENCY//MITOCHONDRIAL HMG COA SYNTHASE |
| 5 | 0.0000096864 | PROGRAM INTEGRAT CARDIAC METAB//HERITAGE MED 423//CARDIAC METABOLISM |
| 6 | 0.0000075433 | PERHEXILINE//HYDROXYPERHEXILINE//PERHEXILINE MALEATE |
| 7 | 0.0000069068 | BENFLURON//9 HYDROXYBENFLURON//BENZOCFLUORENE DERIVATIVES |
| 8 | 0.0000061737 | POTENT ANTIMICROBIALS//UREA THIOUREA//3 OXAZINES |
| 10 | 0.0000054064 | Z 100//BCG VIABILITY//NATURAL IMMUNOMODULATOR |